<p>Serum samples were 3-fold serially diluted from 1:10 to 1:2430, and mixed with an equal volume of medium containing 100 PFU Zika virus then applied on Vero cells. Neutralizing activity was calculated as described in the Materials and Methods. (A) Summary of PRNT<sub>50</sub> titer of each mouse in different experimental groups. Red stars represent significant differences (Student’s t tests) between the PBS control group and the indicated vaccination group against serum dilutions. (C) Two-way ANOVA test, followed by Tukey's correction for multiple comparisons were used to determine statistical differences among curves plotted in (B). The data were presented as mean ± SEM. Each sample was assayed in duplicates and the figures are represent...
<p>Serum antibody (total IgG) elicited by the Zika VLP vaccine (VLP), inactivated Zika virus (In-ZIK...
(a) ZIKV-binding affinity[1] of purified scFvs, 5–1, 7–2, 38–1, 45–3, 51–2 and 63–1. Dilutions of th...
<p>Immune sera were diluted 2-fold stepwise and incubated with virus (100 PFU) at 37°C for 1 h. A st...
<p>Virus-neutralizing antibody activities in sera collected 2 weeks after immunization. Dilutions of...
<p><b>(A)</b> Plaque reduction neutralisation test (PRNT) of DENV2 on Vero cells with sera from mice...
<p>The neutralizing antibody titrations (PRNT<sub>50</sub>) against DENV2 was evaluated in serum sam...
<p>Appropriately diluted viruses were mixed at indicated dilutions with the serum (A), TW (B), or NW...
<p>*Number represents fold dilution of mucosal samples which induced 50% plaque reduction. Six mice ...
<p>(A) Focus-reduction micro-neutralizing test (FRμNT) of UCV-Nakayama–, FIV-Nakayama–and FICV-immun...
<div><p>(A) Mice vaccinated young: icSARS-CoV (left) and icGDO3-S (right) PRNT<sub>80</sub> ...
<p>Serum titers were determined by the dilution at which 50% of plaque viability or luciferase expre...
<p>Serum neutralizing titers (A) and hemagglutination inhibition (HAI) titers (B) were determined at...
<p>Serial dilution (2-fold) of the serum from 2, 3, 5 and 8 week-old mice born to DENV1 immune mothe...
<p>Mice were primed with live RV or γ-RV twice, 2 weeks apart. Serum samples harvested on Day 21 pos...
<p>Neutralizing antibody titers in sera were determined using KAN-1 pseudotyped viruses (A, dose-dep...
<p>Serum antibody (total IgG) elicited by the Zika VLP vaccine (VLP), inactivated Zika virus (In-ZIK...
(a) ZIKV-binding affinity[1] of purified scFvs, 5–1, 7–2, 38–1, 45–3, 51–2 and 63–1. Dilutions of th...
<p>Immune sera were diluted 2-fold stepwise and incubated with virus (100 PFU) at 37°C for 1 h. A st...
<p>Virus-neutralizing antibody activities in sera collected 2 weeks after immunization. Dilutions of...
<p><b>(A)</b> Plaque reduction neutralisation test (PRNT) of DENV2 on Vero cells with sera from mice...
<p>The neutralizing antibody titrations (PRNT<sub>50</sub>) against DENV2 was evaluated in serum sam...
<p>Appropriately diluted viruses were mixed at indicated dilutions with the serum (A), TW (B), or NW...
<p>*Number represents fold dilution of mucosal samples which induced 50% plaque reduction. Six mice ...
<p>(A) Focus-reduction micro-neutralizing test (FRμNT) of UCV-Nakayama–, FIV-Nakayama–and FICV-immun...
<div><p>(A) Mice vaccinated young: icSARS-CoV (left) and icGDO3-S (right) PRNT<sub>80</sub> ...
<p>Serum titers were determined by the dilution at which 50% of plaque viability or luciferase expre...
<p>Serum neutralizing titers (A) and hemagglutination inhibition (HAI) titers (B) were determined at...
<p>Serial dilution (2-fold) of the serum from 2, 3, 5 and 8 week-old mice born to DENV1 immune mothe...
<p>Mice were primed with live RV or γ-RV twice, 2 weeks apart. Serum samples harvested on Day 21 pos...
<p>Neutralizing antibody titers in sera were determined using KAN-1 pseudotyped viruses (A, dose-dep...
<p>Serum antibody (total IgG) elicited by the Zika VLP vaccine (VLP), inactivated Zika virus (In-ZIK...
(a) ZIKV-binding affinity[1] of purified scFvs, 5–1, 7–2, 38–1, 45–3, 51–2 and 63–1. Dilutions of th...
<p>Immune sera were diluted 2-fold stepwise and incubated with virus (100 PFU) at 37°C for 1 h. A st...